# Efavirenz

NDC: 33342-013
Generic name: Efavirenz
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240510

FDA application: ANDA091579

## Active ingredients

- EFAVIRENZ: 600 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-013"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-013
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13ca3456-e5bf-4bb1-af95-b1378658a358